TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 31 filers reported holding TRACON PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $3,015,000 | +6.3% | 900,000 | 0.0% | 0.16% | -2.5% |
| Q3 2017 | $2,835,000 | +31.2% | 900,000 | 0.0% | 0.16% | +20.1% |
| Q2 2017 | $2,160,000 | -36.0% | 900,000 | 0.0% | 0.13% | -39.9% |
| Q1 2017 | $3,375,000 | -20.4% | 900,000 | +4.0% | 0.22% | -19.2% |
| Q4 2016 | $4,241,000 | +21.2% | 865,526 | +67.2% | 0.28% | +29.0% |
| Q3 2016 | $3,500,000 | +54.3% | 517,700 | 0.0% | 0.21% | +54.0% |
| Q2 2016 | $2,268,000 | -37.3% | 517,700 | 0.0% | 0.14% | -31.2% |
| Q1 2016 | $3,619,000 | -24.4% | 517,700 | 0.0% | 0.20% | -15.5% |
| Q4 2015 | $4,784,000 | +21.2% | 517,700 | +28.2% | 0.24% | +4.4% |
| Q3 2015 | $3,946,000 | – | 403,912 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 1,889,652 | $18,462,000 | 1.22% |
| WALL STREET ASSOCIATES | 250,000 | $2,442,000 | 0.47% |
| Eventide Asset Management | 403,912 | $3,946,000 | 0.23% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 485,000 | $4,738,000 | 0.18% |
| J. Goldman & Co LP | 170,000 | $1,661,000 | 0.14% |
| QVT Financial LP | 363,292 | $3,549,000 | 0.12% |
| Kinsight, LLC | 10,053 | $98,000 | 0.07% |
| Welch Group, LLC | 33,769 | $330,000 | 0.06% |
| Visium Asset Management, LP | 436,336 | $4,263,000 | 0.06% |
| Candriam S.C.A. | 135,300 | $1,322,000 | 0.03% |